Skip to the content
  • HOME
  • ABOUT
  • ACTHIV INSTITUTE
  • SERVICES
  • CE ACTIVITIES
    • Gastroentrology
    • Hematology
    • HIV Medicine
    • Infectious Disease
    • Neurology
    • Oncology
    • Opioids
    • Rare Diseases
  • RESOURCES
  • CONTACT

PAH Clinical Research Highlights: CHEST 2024

  • Post author By salmocc
  • Post date February 3, 2025

PAH Clinical Research Highlights: CHEST 2024

 Rare Diseases

Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other members of the care team will receive a certificate of participation.

  • Listing ID: 3152

← Hematologic Malignancies and Clinical Trial Participation: A Shared Decision-Making Approach → Navigating Lung Cancer Screening: Identifying and Engaging High-Risk Individuals